Ask AI
Barbara Burtness

Barbara Burtness, MD

Anthony N. Brady Professor of Medicine
Chief Translational Research Officer
Associate Director, Translational Science
Chief, Head and Neck/Sarcoma Oncology
Co-Leader, Developmental Therapeutics Program
Director, Yale Head and Neck SPORE
Yale Cancer Center
Yale School of Medicine
New Haven, Connecticut

Explore Activities by Barbara Burtness

Title
Format
Credit Type
Credits
ClinicalThought Expert Office Hours Forum: Navigating the Evolving Head and Neck Cancer Treatment Continuum

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts Discuss the Use of Immunotherapy in HNSCC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Driving Progress in HNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Driving Progress in HNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Driving Progress in HNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum

Content Format:

Slideset

Credit Type:

--

Credits:

--
Unfolding Immunotherapy in Head and Neck Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
My Thoughts on IO in HNSCC Today

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Unfolding Immunotherapy in Head and Neck Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Practice Update: Exploring New Approaches in Head and Neck Squamous Cell Carcinoma

Content Format:

Text Module

Credit Type:

AAPA | ANCC

Credits:

1.00
ExpressPoints: Clinical Application of New Advances in the Treatment of Head and Neck Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Therapy Recommendations for Recurrent Locoregionally Advanced and Metastatic Head and Neck Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
Exploring Future Roles for Immune-Oncology in Head and Neck Cancer: Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--
Exploring Future Roles for Immune-Oncology in Head and Neck Cancer

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
The Current Treatment Landscape in Head and Neck Cancer: Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--
The Current Treatment Landscape in Head and Neck Cancer

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
The Evolution of Immunotherapy in Head and Neck Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Expert Guidance on the Expanding Role of Immunotherapy in HNSCC

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Expert Guidance on the Expanding Role of Immunotherapy in HNSCC: Downloadable Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--